Suppr超能文献

小鼠NKG2D配体:“双重辛劳与麻烦” 。

Murine NKG2D ligands: "double, double toil and trouble".

作者信息

Samarakoon Asanga, Chu Haiyan, Malarkannan Subramaniam

机构信息

Laboratory of Molecular Immunology, Blood Research Institute, Division of Neoplastic Diseases, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI 53226, United States.

出版信息

Mol Immunol. 2009 Mar;46(6):1011-9. doi: 10.1016/j.molimm.2008.09.035. Epub 2008 Dec 10.

Abstract

Unlike T and B cells, NK cells lack variable, clonotypic receptors that recognize foreign antigens. Instead, NK cells depend on conserved receptors such as NKG2D. NKG2D recognizes a variety of inducible self-proteins that belong to the non-classical MHC class I family. They include ULBP (1-3), MIC (A & B) in human and H60 (a, b & c), Rae-1 (alpha-epsilon) and Mult1 in mice. These self-proteins are expressed due to pathological stimuli, share limited amino acid homology and form the molecular basis for NKG2D-mediated activation. Recent studies have vastly improved our understanding of NKG2D receptor-mediated activation, signaling and function. However, a detailed knowledge on the immunobiology of its ligands is lacking. How many is too many? Is NKG2D the only receptor for these ligands? Where are these ligands expressed? What are the molecular mechanisms that regulate their expression? Do normal cells express these ligands? Does the communication between NKG2D receptor and its ligands travel through a two way road? If so, what do the 'target' cells get in turn, only death? How efficient are these ligands as molecular targets for NK cell-mediated tumor immunotherapy?

摘要

与T细胞和B细胞不同,自然杀伤(NK)细胞缺乏识别外来抗原的可变克隆型受体。相反,NK细胞依赖于保守受体,如NKG2D。NKG2D识别多种属于非经典MHC I类家族的可诱导自身蛋白。它们包括人类的ULBP(1 - 3)、MIC(A和B)以及小鼠的H60(a、b和c)、Rae - 1(α - ε)和Mult1。这些自身蛋白因病理刺激而表达,氨基酸同源性有限,构成了NKG2D介导的激活的分子基础。最近的研究极大地增进了我们对NKG2D受体介导的激活、信号传导和功能的理解。然而,关于其配体的免疫生物学的详细知识仍然缺乏。多少才算过多?NKG2D是这些配体的唯一受体吗?这些配体在哪里表达?调节它们表达的分子机制是什么?正常细胞会表达这些配体吗?NKG2D受体与其配体之间的通讯是双向的吗?如果是,“靶”细胞反过来会得到什么,只有死亡吗?这些配体作为NK细胞介导的肿瘤免疫治疗的分子靶点效率如何?

相似文献

1
Murine NKG2D ligands: "double, double toil and trouble".
Mol Immunol. 2009 Mar;46(6):1011-9. doi: 10.1016/j.molimm.2008.09.035. Epub 2008 Dec 10.
2
Antitumor immunity. A shed NKG2D ligand that promotes natural killer cell activation and tumor rejection.
Science. 2015 Apr 3;348(6230):136-9. doi: 10.1126/science.1258867. Epub 2015 Mar 5.
3
4
A dual function of NKG2D ligands in NK-cell activation.
Eur J Immunol. 2012 Sep;42(9):2452-8. doi: 10.1002/eji.201141849. Epub 2012 Jul 27.
5
Four novel ULBP splice variants are ligands for human NKG2D.
Int Immunol. 2008 Aug;20(8):981-91. doi: 10.1093/intimm/dxn057. Epub 2008 Jun 10.
6
Critical role of the NKG2D receptor for NK cell-mediated control and immune escape of B-cell lymphoma.
Eur J Immunol. 2015 Sep;45(9):2593-601. doi: 10.1002/eji.201445375. Epub 2015 Jul 7.
7
Expression of NKG2D and its ligand in mouse heart allografts may have a role in acute rejection.
Transplant Proc. 2009 Dec;41(10):4332-9. doi: 10.1016/j.transproceed.2009.08.060.
9
NKG2D and Its Ligands: "One for All, All for One".
Front Immunol. 2018 Mar 12;9:476. doi: 10.3389/fimmu.2018.00476. eCollection 2018.

引用本文的文献

1
The current state of knowledge on the role of NKG2D ligands in multiple sclerosis and other autoimmune diseases.
Front Mol Neurosci. 2025 Jan 10;17:1493308. doi: 10.3389/fnmol.2024.1493308. eCollection 2024.
2
Role of Toll-like receptors in natural killer cell function in acute lymphoblastic leukemia.
Oncol Lett. 2021 Nov;22(5):748. doi: 10.3892/ol.2021.13009. Epub 2021 Aug 24.
3
The Role of microRNAs in NK Cell Development and Function.
Cells. 2021 Aug 7;10(8):2020. doi: 10.3390/cells10082020.
4
Implications of a 'Third Signal' in NK Cells.
Cells. 2021 Jul 31;10(8):1955. doi: 10.3390/cells10081955.
5
Tissue-Resident NK Cells: Development, Maturation, and Clinical Relevance.
Cancers (Basel). 2020 Jun 12;12(6):1553. doi: 10.3390/cancers12061553.
6
Engineering of chimeric natural killer cell receptors to develop precision adoptive immunotherapies for cancer.
Clin Exp Immunol. 2020 Oct;202(1):11-27. doi: 10.1111/cei.13478. Epub 2020 Jul 25.
7
Disrupts Inflammatory but Not Cytotoxic Responses of NK Cells.
Cancer Immunol Res. 2019 Oct;7(10):1647-1662. doi: 10.1158/2326-6066.CIR-18-0934. Epub 2019 Sep 12.
9
Natural Killer Cells: Development, Maturation, and Clinical Utilization.
Front Immunol. 2018 Aug 13;9:1869. doi: 10.3389/fimmu.2018.01869. eCollection 2018.

本文引用的文献

2
Blockade of NKG2D on NKT cells prevents hepatitis and the acute immune response to hepatitis B virus.
Proc Natl Acad Sci U S A. 2007 Nov 13;104(46):18187-92. doi: 10.1073/pnas.0708968104. Epub 2007 Nov 8.
3
The Piwi-piRNA pathway provides an adaptive defense in the transposon arms race.
Science. 2007 Nov 2;318(5851):761-4. doi: 10.1126/science.1146484.
4
PAML 4: phylogenetic analysis by maximum likelihood.
Mol Biol Evol. 2007 Aug;24(8):1586-91. doi: 10.1093/molbev/msm088. Epub 2007 May 4.
5
The herpesviral Fc receptor fcr-1 down-regulates the NKG2D ligands MULT-1 and H60.
J Exp Med. 2006 Aug 7;203(8):1843-50. doi: 10.1084/jem.20060514. Epub 2006 Jul 10.
6
NKG2D-independent suppression of T cell proliferation by H60 and MICA.
Proc Natl Acad Sci U S A. 2005 Aug 16;102(33):11805-10. doi: 10.1073/pnas.0502026102. Epub 2005 Aug 9.
7
The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor.
Nature. 2005 Aug 25;436(7054):1186-90. doi: 10.1038/nature03884. Epub 2005 Jul 3.
8
Selective down-regulation of the NKG2D ligand H60 by mouse cytomegalovirus m155 glycoprotein.
J Virol. 2005 Mar;79(5):2920-30. doi: 10.1128/JVI.79.5.2920-2930.2005.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验